These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26938573)

  • 21. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACOG Practice Bulletin No. 27: Clinical Management Guidelines for Obstetrician-Gynecologists. Prenatal diagnosis of fetal chromosomal abnormalities.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2001 May; 97(5 Pt 1):suppl 1-12. PubMed ID: 11501567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No. 261-Prenatal Screening for Fetal Aneuploidy in Singleton Pregnancies.
    Chitayat D; Langlois S; Wilson RD
    J Obstet Gynaecol Can; 2017 Sep; 39(9):e380-e394. PubMed ID: 28859781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results.
    Pryde PG; Drugan A; Johnson MP; Isada NB; Evans MI
    Clin Obstet Gynecol; 1993 Sep; 36(3):496-509. PubMed ID: 8403601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preferences of pregnant women for amniocentesis or chorionic villus sampling for prenatal testing: comparison of patients' choices and those of a decision-analytic model.
    Heckerling PS; Verp MS; Hadro TA
    J Clin Epidemiol; 1994 Nov; 47(11):1215-28. PubMed ID: 7722557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age.
    Hagen A; Entezami M; Gasiorek-Wiens A; Albig M; Becker R; Knoll U; Stumm M; Wegner RD
    Ultraschall Med; 2011 Jun; 32(3):302-6. PubMed ID: 20972947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal genetic testing 2: diagnostic tests.
    Jenkins M; Seasely AR; Subramaniam A
    Curr Opin Pediatr; 2022 Dec; 34(6):553-558. PubMed ID: 36081360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive prenatal screening or advanced diagnostic testing: caveat emptor.
    Evans MI; Wapner RJ; Berkowitz RL
    Am J Obstet Gynecol; 2016 Sep; 215(3):298-305. PubMed ID: 27131582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of non-invasive prenatal testing in late gestation in a pregnancy associated with intrauterine growth restriction and trisomy 22 confined placental mosaicism.
    Chen CP; Tsai C; Lin MH; Chern SR; Chen SW; Lai ST; Chen WL; Pan CW; Wang W
    Taiwan J Obstet Gynecol; 2017 Oct; 56(5):691-693. PubMed ID: 29037560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2007 Dec; 110(6):1459-67. PubMed ID: 18055749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal genetic diagnosis of Down's syndrome.
    Abbott MA; Benn P
    Expert Rev Mol Diagn; 2002 Nov; 2(6):605-15. PubMed ID: 12465456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome.
    Viuff MH; Stochholm K; Uldbjerg N; Nielsen BB; ; Gravholt CH
    Hum Reprod; 2015 Oct; 30(10):2419-26. PubMed ID: 26251461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.
    Hume H; Chasen ST
    Am J Obstet Gynecol; 2015 Oct; 213(4):545.e1-4. PubMed ID: 26070711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
    Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-invasive chromosome test raises new questions in prenatal diagnosis about the significance of ultrasound and questions about new screening strategies.
    Tercanli S; Vial Y; Merz E
    Ultraschall Med; 2013 Oct; 34(5):417-20. PubMed ID: 24127381
    [No Abstract]   [Full Text] [Related]  

  • 40. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.
    Wax JR; Cartin A; Chard R; Lucas FL; Pinette MG
    J Clin Ultrasound; 2015 Jan; 43(1):1-6. PubMed ID: 25303161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.